Kestra Advisory Services, LLC Repligen Corp Transaction History

Kestra Advisory Services, LLC

  • $20.1 Billion
  • Q3 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 31, 2023
BUY
$162.42 - $220.56 $205,461 - $279,008
1,265 New
1,265 $214,000
Q2 2022

Aug 12, 2022
SELL
$140.68 - $188.02 $201,453 - $269,244
-1,432 Reduced 53.14%
1,263 $205,000
Q1 2022

Apr 26, 2022
BUY
$161.19 - $257.96 $115,089 - $184,183
714 Added 36.04%
2,695 $506,000
Q4 2021

Jan 20, 2022
BUY
$247.59 - $304.47 $27,977 - $34,405
113 Added 6.05%
1,981 $524,000
Q3 2021

Oct 19, 2021
BUY
$194.77 - $324.21 $363,830 - $605,624
1,868 New
1,868 $539,000

Others Institutions Holding RGEN

# of Institutions
526
Shares Held
59.2M
Call Options Held
321K
Put Options Held
667K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Kestra Advisory Services, LLC Portfolio

Follow Kestra Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email